New study explores urinary management in people with spinal cord injury
Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
Read moreAll news
Rethink Medical reaches the minimum target of its 2026 investment round
Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.
The financing supports the company's next stage of development as it progresses its manufacturing, regulatory, commercial and internationalisation activities around T-Control®.
We thank the investors and supporters who continue to accompany Rethink Medical through this next phase.
More news
Rethink Medical presents T-Control® at the 48th Spanish Neuroscience Nursing Congress
Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.
Read more
Rethink Medical participates in WHX Dubai 2026
Rethink Medical participated in WHX Dubai 2026, one of the major international meeting points for the healthcare and medical-technology sector.
Read more